ATE414082T1 - Antibiotische tetrahydro-b-carbolinderivative - Google Patents

Antibiotische tetrahydro-b-carbolinderivative

Info

Publication number
ATE414082T1
ATE414082T1 AT04750953T AT04750953T ATE414082T1 AT E414082 T1 ATE414082 T1 AT E414082T1 AT 04750953 T AT04750953 T AT 04750953T AT 04750953 T AT04750953 T AT 04750953T AT E414082 T1 ATE414082 T1 AT E414082T1
Authority
AT
Austria
Prior art keywords
carboline derivatives
tetrahydro
ppat
structural formula
bacteria
Prior art date
Application number
AT04750953T
Other languages
English (en)
Inventor
Timothy Opperman
Anthony Arvanites
Julia Pinto
Yibin Xiang
Syed Ali
Bolin Geng
Mark Ashwell
Alan Kaplan
Original Assignee
Oscient Pharmaceuticals
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oscient Pharmaceuticals, Arqule Inc filed Critical Oscient Pharmaceuticals
Application granted granted Critical
Publication of ATE414082T1 publication Critical patent/ATE414082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Maintenance And Management Of Digital Transmission (AREA)
AT04750953T 2003-04-29 2004-04-29 Antibiotische tetrahydro-b-carbolinderivative ATE414082T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46653703P 2003-04-29 2003-04-29

Publications (1)

Publication Number Publication Date
ATE414082T1 true ATE414082T1 (de) 2008-11-15

Family

ID=33418394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04750953T ATE414082T1 (de) 2003-04-29 2004-04-29 Antibiotische tetrahydro-b-carbolinderivative

Country Status (8)

Country Link
US (1) US20060273819A1 (de)
EP (1) EP1628977B1 (de)
JP (1) JP2006525347A (de)
AT (1) ATE414082T1 (de)
AU (1) AU2004234405A1 (de)
CA (1) CA2524125A1 (de)
DE (1) DE602004017714D1 (de)
WO (1) WO2004096802A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8571070B2 (en) 2005-12-02 2013-10-29 Broadcom Corporation Method and system for speed negotiation for twisted pair links in fibre channel sytems
EP2225250A2 (de) * 2007-11-30 2010-09-08 Biota Scientific Management Pty Ltd Bicyclische ppat-inhibitoren als antibakterielle mittel
CA2707442A1 (en) * 2007-11-30 2009-08-20 Biota Scientific Management Pty Ltd Antibiotic tetrahydro-beta-carboline derivatives
EP2300932A4 (de) * 2008-07-15 2012-05-02 Lsi Corp System zum einspeisen von protokollspezifischen fehlern während der zertifizierung von komponenten in einem speichernetzwerk
US9319348B2 (en) * 2011-05-24 2016-04-19 Cisco Technology, Inc. Octal serial gigabit media-independent interface
EP3130583B1 (de) 2012-04-05 2024-01-03 CHDI Foundation, Inc. Kynurenin-3-monooxygenase-hemmer, pharmazeutische zusammensetzungen und verfahren zur verwendung davon
EP2775652B1 (de) * 2013-03-07 2018-08-22 Viavi Solutions Deutschland GmbH Bitfehlermusteranalysegerät und Verfahren
ES2754473T3 (es) 2013-09-26 2020-04-17 Chdi Foundation Inc Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas, y método de uso de los mismos
US9884853B2 (en) 2013-09-26 2018-02-06 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US9531625B2 (en) 2015-01-28 2016-12-27 Ciena Corporation System and method for providing redundant network connections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055203A (en) * 1964-09-16 1967-01-18 Ici Ltd -ß-carboline derivatives, a process for their manufacture, and compositions containing them
US4283536A (en) * 1977-12-29 1981-08-11 University Of Vermont Preparation of vincadifformine and related derivatives
FR2619111B1 (fr) * 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
AR024158A1 (es) * 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
FR2796644B1 (fr) * 1999-07-23 2001-09-07 Adir Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6469020B2 (en) * 2000-05-15 2002-10-22 Darwin Discovery, Ltd. Hydroxamic and carboxylic acid derivatives
US6720330B2 (en) * 2000-11-17 2004-04-13 Pfizer Inc. Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
US6987115B2 (en) * 2000-12-08 2006-01-17 Smithkline Beecham Corporation Antibacterial compounds
DE60216233T2 (de) * 2001-02-12 2007-09-27 Lilly Icos Llc, Wilmington Carbolinderivate
DE60112974T2 (de) * 2001-02-12 2006-02-16 Lilly Icos Llc, Wilmington Carbolinderivate
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
TWI329111B (en) * 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents

Also Published As

Publication number Publication date
WO2004096802A2 (en) 2004-11-11
WO2004096802A9 (en) 2005-01-20
EP1628977B1 (de) 2008-11-12
EP1628977A2 (de) 2006-03-01
WO2004096802A3 (en) 2005-05-12
JP2006525347A (ja) 2006-11-09
AU2004234405A1 (en) 2004-11-11
CA2524125A1 (en) 2004-11-11
DE602004017714D1 (de) 2008-12-24
US20060273819A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
WO2009073545A3 (en) Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents
DE60309701D1 (de) 2-ureido-6-heteroaryl-3h-benzoimidazol-4-carbonsäurederivate und verwandte verbindungen als gyrase und/oder topoisomerase iv inhibitoren zur behandlung von bakteriellen infektionen
WO2007014372A3 (en) Compositions and methods for treating bacteria
TW200734344A (en) Antibacterial agents
WO2006120563A3 (en) Antibacterial agents
DK1913004T3 (da) 8-methoxy-9h-isothiazolo[5,4-b]quinolin-3,4-dioner og beslægtede forbindelser som antiinfektive midler
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
NO20074703L (no) Antibakterielle piperidinderivater
DE69433901D1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
WO2007085852A3 (en) Antimicrobial materials
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
NZ510369A (en) Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
ATE414082T1 (de) Antibiotische tetrahydro-b-carbolinderivative
WO2009073534A3 (en) Bicyclic ppat inhibitors as antibacterial agents
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
ATE509018T1 (de) Als antimikrobielle mittel geeignete bisindolpyrrole
WO2009102377A3 (en) Antibiotic tetrahydro-beta-carboline derivatives
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
BRPI0417421A (pt) composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado
EA200901059A1 (ru) Макролиды на основе эритромицина
NO20080314L (no) Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties